1 |
Xu WJ, Gao Z, Li QS, Li CR, Zhao CY. Non-dilated coronary artery lesion and myocardial perfusion in children with Kawasaki disease: analysis of 43 cases. Zhonghua Er Ke Za Zhi 2004;42:613-6
PUBMED
|
2 |
Takeuchi D, Saji T, Takatsuki S, Fufwara M. Abnormal tissue doppler images are associated with elevated plasma brain nariuretic peptide and increased oxidatve stress in acute Kawasaki disease. Circ J 2007;71:357-62
DOI
ScienceOn
|
3 |
Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42:1065-74
DOI
ScienceOn
|
4 |
Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54
DOI
ScienceOn
|
5 |
Burn JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki Disease: A Brief History. Pediatrics 2000;106:e27
DOI
PUBMED
ScienceOn
|
6 |
Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6
DOI
ScienceOn
|
7 |
Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90
DOI
ScienceOn
|
8 |
Keller P, Moller K, Krabbe KS, Pedersen BK. Circulating adiponectin levels during human endotoxaemia. Clin Exp Immunol 2003;134:107-10
DOI
PUBMED
ScienceOn
|
9 |
Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:1127-33
DOI
ScienceOn
|
10 |
Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Pediatr 2006;95:1312-4
DOI
ScienceOn
|
11 |
Donovan CL, Armstrong WF, Bach DS. Quantitatve doppler tissue imaging of the left ventricular myocardium: Validation in normal subjects. Am Heart J 1995;130:100-4
DOI
ScienceOn
|
12 |
Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8
DOI
ScienceOn
|
13 |
Newburger JW, Burns JC. Kawasaki disease. Vascular Med 1999;4:187-202
DOI
|
14 |
Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1,100 cases. Pediatr Cardiol 1986;7:3-9
DOI
ScienceOn
|
15 |
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104-10
DOI
PUBMED
ScienceOn
|
16 |
Yamauchi T, Kamon J, Waki H, Terauchi t, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6
DOI
ScienceOn
|
17 |
Masuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-91
DOI
ScienceOn
|
18 |
Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: Noninvasive technique for evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80
DOI
ScienceOn
|
19 |
Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42:231-4
DOI
ScienceOn
|
20 |
Cavusoglu E, Chopra V, Battala V, Ruwende C, Yanamadala S, Eng C, et al. Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patient referred for coronary angiograpy. Am J Cardiol 2008;101:1073-8
DOI
ScienceOn
|
21 |
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49
DOI
ScienceOn
|
22 |
Okamoto Y, Arita Y, Nishida M, Maraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheares to injured vascular walls. Horm Metab Res 2000;32:47-50
DOI
ScienceOn
|
23 |
Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992;151:44-7
DOI
ScienceOn
|
24 |
Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol 2004;43:653-61
DOI
ScienceOn
|
25 |
Hauser M, Bengel F, Kuehn A, Nekolla S, Kaemmerer H, Schwaiger M, et al. Myocardial blood flow and coronary flow reserve in children with normal epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography. Pediatr Cardiol 2004;25:108-12
DOI
ScienceOn
|
26 |
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 1974;54:271-6
PUBMED
ScienceOn
|
27 |
Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J Biol Chem 2002;278:2641-8
|
28 |
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21- year follow-up study of 594 patients. Circulation 1996;94:1379-85
PUBMED
ScienceOn
|
29 |
Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44
DOI
ScienceOn
|